About this trial
RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing colonoscopy or endoscopy for diagnostic or screening purposes at the Vanderbilt University Medical Center or at the Veterans Affairs Medical Center AND
Diagnosis of gastrointestinal (GI) cancer, polyps, or inflammatory bowel disease
History of previously treated GI cancer, polyps, or inflammatory bowel disease
Capable of giving informed consent
Disqualifiers
None
Trial population
Vanderbilt University Medical Center patients with GI malignancy
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Identification of new potential biomarkers of increased gastrointestinal cancer risk using tissue and biofluid samples from patients undergoing colonoscopy, endoscopy, or surgery
Genomic and proteomic biomarkers
Development of new screening strategies based on substances found in tissue and biofluid samples
Genomic and proteomic biomarker discovery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Vanderbilt University Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator